PARP inhibitors (Crimson Pharmaceutical)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePARP inhibitors (Crimson Pharmaceutical)
Drug Alias NamePARP inhibitors (Octamer)CPH-101 (Crimson Pharma)INH2BP (Octamer)INH2BP (Crimson Pharmaceutical)CPH-102 +[6] 
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectantsPoly (ADP-Ribose) polymerase inhibitors
TargetsPoly (ADP-Ribose) polymerase
Therapy Area/IndicationsInflammationStrokeNeoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOctamer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOctamer IncCrimson Pharmaceutical (Hong Kong) Ltd
Active IndicationsN/A
Inactive IndicationsInflammationStrokeNeoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A